Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
0%
ALSO IN XDNA
XDNA
3
HOLDINGS
nan%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
MEDX Overweight Relative to XDNA
 |
ELI LILLY & CO | 14.4% |
|
ABBVIE INC | 9.4% |
 |
NOVARTIS AG-ADR | 6.7% |
|
ALNYLAM PHARMACEUTICALS INC | 6.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% |
|
JOHNSON & JOHNSON | 5.0% |
|
IONIS PHARMACEUTICALS, INC. | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 3.9% |
|
CRISPR THERAPEUTICS AG | 3.9% |
|
AMGEN INC | 3.8% |
MEDX Underweight Relative to XDNA
 |
MURAL ONCOLOGY PLC | 0.0% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.1% |
|
ALLOGENE THERAPEUTICS, INC. | 0.1% |
|
VIATRIS, INC. | 0.2% |
|
REPLIMUNE GROUP, INC. | 0.3% |
|
GE HEALTHCARE TECHNOLOGIES INC. | 0.4% |
|
LANTERN PHARMA, INC. | 0.6% |
|
EDITAS MEDICINE, INC. | 0.6% |
|
VANDA PHARMACEUTICALS INC | 0.7% |
|
BEAM THERAPEUTICS, INC. | 1.3% |